Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by longterm56on Dec 11, 2017 8:57pm

135 Views

Post# 27134723

RE:Prediction: we are closing the gap today or tommorow

CandideV007 wrote: I've said it a few days ago, technically, this one was going to reach around 6.50$ at some point before bouncing. I feel that we are right there. If the overall market remains the same over the next weeks, my feeling is that we will see the share price bounce from now on.

If you say it twice does it mean more?
If you say it twice does it mean more?

Bullboard Posts

UniDoc brings AI-powered H3 Health Cube to Italy